110 related articles for article (PubMed ID: 3495635)
1. Uptake, release, and subcellular localization of 1-methyl-4-phenylpyridinium in blood platelets.
Cesura AM; Ritter A; Picotti GB; Da Prada M
J Neurochem; 1987 Jul; 49(1):138-45. PubMed ID: 3495635
[TBL] [Abstract][Full Text] [Related]
2. Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.
Cesura AM; Bertocci B; Da Prada M
Eur J Pharmacol; 1990 Sep; 186(1):95-104. PubMed ID: 2149340
[TBL] [Abstract][Full Text] [Related]
3. Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.
Reinhard JF; Diliberto EJ; Viveros OH; Daniels AJ
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8160-4. PubMed ID: 2891137
[TBL] [Abstract][Full Text] [Related]
4. An in vitro model of 1-methyl-4-phenyl-pyridinium (MPP+) toxicity: incubation of rabbit caudate nucleus slices with MPP+ followed by biochemical and functional analysis.
Feuerstein TJ; Hedler L; Jackisch R; Hertting G
Br J Pharmacol; 1988 Oct; 95(2):449-58. PubMed ID: 3265882
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
Shen RS; Abell CW; Gessner W; Brossi A
FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of the transport of the quaternary ammonium 1-methyl-4-phenylpyridinium by chromaffin granules.
Darchen F; Scherman D; Desnos C; Henry JP
Biochem Pharmacol; 1988 Nov; 37(22):4381-7. PubMed ID: 3264161
[TBL] [Abstract][Full Text] [Related]
7. Uptake, metabolism and subcellular localization of MPTP and MPP+ in blood platelets.
Da Prada M; Kettler R
Clin Neuropharmacol; 1986; 9 Suppl 4():347-9. PubMed ID: 3494510
[No Abstract] [Full Text] [Related]
8. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
Chiba K; Trevor AJ; Castagnoli N
Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
[TBL] [Abstract][Full Text] [Related]
9. Content and subcellular localization of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma.
Da Prada M; Picotti GB
Br J Pharmacol; 1979 Apr; 65(4):653-62. PubMed ID: 571302
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
[TBL] [Abstract][Full Text] [Related]
11. Uptake of 5-hydroxytryptamine in blood platelets and its inhibition by drugs: role of plasma membrane and granular storage.
Laubscher A; Pletscher A
J Pharm Pharmacol; 1979 May; 31(5):284-9. PubMed ID: 37296
[TBL] [Abstract][Full Text] [Related]
12. 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes.
Willoughby J; Cowburn RF; Hardy JA; Glover V; Sandler M
J Neurochem; 1989 Feb; 52(2):627-31. PubMed ID: 2783454
[TBL] [Abstract][Full Text] [Related]
13. Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter.
Scholze P; Zwach J; Kattinger A; Pifl C; Singer EA; Sitte HH
J Pharmacol Exp Ther; 2000 Jun; 293(3):870-8. PubMed ID: 10869387
[TBL] [Abstract][Full Text] [Related]
14. Effect of ascorbic acid on the synaptosomal uptake of [3H]MPP+, [3H]dopamine, and [14C]GABA.
Sershen H; Debler EA; Lajtha A
J Neurosci Res; 1987; 17(3):298-301. PubMed ID: 3496464
[TBL] [Abstract][Full Text] [Related]
15. Interaction of 1-methyl-4-phenylpyridinium ion with human platelets.
Buckman TD; Chang R; Sutphin MS; Eiduson S
Biochem Biophys Res Commun; 1988 Mar; 151(2):897-904. PubMed ID: 3258155
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cellular transport, subcellular distribution, and secretion of the neurotoxicant 1-methyl-4-phenylpyridinium in bovine adrenomedullary cell cultures.
Reinhard JF; Diliberto EJ; Daniels AJ
J Neurochem; 1989 Apr; 52(4):1253-9. PubMed ID: 2926400
[TBL] [Abstract][Full Text] [Related]
18. Isolated 5-hydroxytryptamine organelles of rabbit blood platelets: physiological properties and drug-induced changes.
Da Prada M; Pletscher A
Br J Pharmacol; 1968 Nov; 34(3):591-7. PubMed ID: 5726788
[TBL] [Abstract][Full Text] [Related]
19. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
Mytilineou C; Cohen G
J Neurochem; 1985 Dec; 45(6):1951-3. PubMed ID: 3932598
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures.
Friedman LK; Mytilineou C
J Pharmacol Exp Ther; 1990 May; 253(2):892-8. PubMed ID: 2338661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
